Twelve antiretroviral treatment centres under National AIDS Control Programme (NACP), Karnataka State, India.For the period 2004-2011, to describe the trends in the numbers of people living with HIV (PLHIV) registered for care and their median baseline CD4 counts, disaggregated by age and sex.Descriptive study involving analysis of routinely captured data (year of registration, age, sex, baseline CD4 count) under NACP.34,882 (97% of total eligible) PLHIV were included in analysis. The number registered for care has increased by over 12 times during 2004-11; with increasing numbers among females. The median baseline CD4 cell count rose from 125 in 2004 to 235 in 2011 – the increase was greater among females as compared to males. However, abo...
Abstract Background The massive scale-up of antiretroviral treatment (ART) access worldwide has brou...
BACKGROUND: Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART)...
Context : The introduction of highly effective generic antiretroviral drugs at reduced cost has tran...
Twelve antiretroviral treatment centres under National AIDS Control Programme (NACP), Karnataka Stat...
The National AIDS control programme (NACP) in India is currently following the World Health Organiza...
The National AIDS control programme (NACP) in India is currently following the World Health Organiza...
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...
In many resource-poor countries, CD4 count thresholds of eligibility for antiretroviral treatment (A...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Background: Lower CD4 count at initiation of antiretroviral therapy (ART) can have a significant neg...
OBJECTIVE: To compare the potential population-level impact of expanding antiretroviral treatment (A...
Background: Understanding the expected effects of different antiretroviral regimens on CD4 count wil...
Background: HIV treatment and care services were scaled up in 2007 in India with objective to increa...
Background. A decade after the detection of human immuno-deficiency virus (HIV) infection in India, ...
BackgroundAn estimated 2.5 million Indians are currently living with HIV. In 2004, the Indian govern...
Abstract Background The massive scale-up of antiretroviral treatment (ART) access worldwide has brou...
BACKGROUND: Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART)...
Context : The introduction of highly effective generic antiretroviral drugs at reduced cost has tran...
Twelve antiretroviral treatment centres under National AIDS Control Programme (NACP), Karnataka Stat...
The National AIDS control programme (NACP) in India is currently following the World Health Organiza...
The National AIDS control programme (NACP) in India is currently following the World Health Organiza...
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...
In many resource-poor countries, CD4 count thresholds of eligibility for antiretroviral treatment (A...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Background: Lower CD4 count at initiation of antiretroviral therapy (ART) can have a significant neg...
OBJECTIVE: To compare the potential population-level impact of expanding antiretroviral treatment (A...
Background: Understanding the expected effects of different antiretroviral regimens on CD4 count wil...
Background: HIV treatment and care services were scaled up in 2007 in India with objective to increa...
Background. A decade after the detection of human immuno-deficiency virus (HIV) infection in India, ...
BackgroundAn estimated 2.5 million Indians are currently living with HIV. In 2004, the Indian govern...
Abstract Background The massive scale-up of antiretroviral treatment (ART) access worldwide has brou...
BACKGROUND: Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART)...
Context : The introduction of highly effective generic antiretroviral drugs at reduced cost has tran...